Another important distinction for Medochemie Hellas was achieved on Thursday, November 1st, 2018 during the “Salus Index 2018” Business Excellence Awards organized by New Times Publishing Group.
Mr. Antonis Evmorfiades, Medochemie Hellas CEO, received the award for the company’s remarkable growth and during his speech, he highlighted the challenges of doing business in a highly negative environment for pharmaceutical companies and dedicated this distinction to the company's employees.
During the ceremony businesses with the greatest growth potential were rewarded.